U.S. biotech startups may IPO in Hong Kong πŸ“ˆ

How salad became a major source of food poisoning in the U.S., a deep dive into how scientists can repurpose a bacterial immune system to alter DNA and other interesting reads from the past week.

Noteworthy πŸ“°

China reverses course on cancer drug import tax. Link

Bill Gates to donate $12 million to develop a universal flu vaccine. Link

Takeda inches closer to scooping up Shire. Link

U.S. biotech startups may IPO in Hong Kong. Link

East Africa unveils a plan to bridge drugs manufacturing gap. Link

Digital Health πŸ’»

FDA expands its AI, digital health push. Link

Novartis keeps the focus on digital with eye disease app. Link

Research πŸ”¬

44 genetic risk factors for depression. Link

Drinking baking soda could be an inexpensive, safe way to combat autoimmune disease. Link

Perspective and Opinions πŸ“’

How high drug prices and big lobbying budgets go together for big pharma. Link

Even clinical trials can be fake now β€” here’s how to spot one. Link

Why it’s so hard for doctors to understand your pain. Link

Interesting πŸ€”

How salad became a major source of food poisoning in the US. Link

Drinking alcohol may change the bacteria in your mouth. Link

Mosquitoes kill more people in a day than sharks do in a century. Link

Startups of the Week πŸ’°

Corvidia Therapeutics is a clinical stage biotechnology company pioneering the next generation of cardiovascular and cardio-renal therapies. Closed a $60m Series B funding round.

Rallybio develops innovative drug candidates against mechanisms that have biological rationales focusing on antibodies, small molecules and engineered proteins. Secured $37m in Series A funding.

EryDel develops an innovative red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Raised €26.5M in financing.

NuProbe is advancing an ultra-sensitive, non-invasive blood test for the early detection of cancer and infectious diseases. Raised $11m in Series A funding.

Deep Dive πŸ‘“

How scientists can repurpose a bacterial immune system to alter DNA, making everything from cheap insulin to extra starchy corn.

Our Digital Times πŸ˜ƒ